Hologic (HOLX) Tops Q2 EPS by 1c; Bumps Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Needham & Company Downgrades Hologic (HOLX) to Hold
April 28, 2016 7:36 AM EDTNeedham & Company downgraded Hologic (NASDAQ: HOLX) from Buy to Hold.
Analyst Mike Matson commented, "HOLX's F2Q16 revenue and EPS beat consensus and management raised its FY16 guidance. HOLX's revenue growth slowed to 6% CC in F2Q16 from 8% CC in F1Q16. Positives... More
